This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 21/9/2124    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wiper-Bergeron, N. Articles by Lee, J. M. Search for Related Content PubMed PubMed Citation Articles by Wiper-Bergeron, N. Articles by Lee, J. M.

CCAAT/Enhancer Binding Protein ß Abrogates Retinoic Acid-Induced Osteoblast Differentiation via Repression of Runx2 Transcription

Department of Cellular and Molecular Medicine (N.W.-B., C.S-L.) and Department of Biochemistry, Microbiology and Immunology (N.W.-B., J.M.L.), University of Ottawa, Ottawa, Ontario, Canada K1H 8M5

Address all correspondence and requests for reprints to: Dr. Nadine Wiper-Bergeron, 451 Smyth Road, Ottawa, Ontario, Canada K1H 8M5. E-mail: Nadine.WiperBergeron{at}uottawa.ca.

Runx2/CBFA1/AML3 is a master regulator of the osteoblast lineage and has been shown to directly control the transcription of numerous osteoblast-specific genes including alkaline phosphatase, osteopontin, and type I collagen. In its absence, ossification does not occur during development resulting in animals with cartilaginous skeletons and no osteoblasts. In humans, loss of one copy of Runx2 causes cleidocranial dysplasia characterized by malformations of the facial and cranial bones and the clavicle. Despite its important role in osteoblast biology, relatively little is known about the transcriptional regulation of the Runx2 gene. In the present study, we show that CCAAT/enhancer binding protein ß (C/EBPß) is a negative regulator of Runx2 expression and acts by directly binding a C/EBP element located at –591/–576 within the osteoblast-specific Runx2 P1 promoter. Ectopic expression of C/EBPß in C3H10T1/2 cells causes a reduction in Runx2 expression concomitant with a decrease in osteogenic potential during all-trans retinoic acid (ATRA)-induced differentiation. In nondifferentiating cells, C/EBPß can be found occupying the C/EBP negative response element within the Runx2 P1 promoter. ATRA, the effects of which are mediated by retinoic acid receptor and in C3H10T1/2 cells, stimulates the dissociation of C/EBPß from this element and promotes Runx2 expression. Thus, ATRA initiates osteoblastic differentiation of C3H10T1/2 cells, at least in part, by triggering the dissociation of C/EBPß from the Runx2 promoter.